MedTrace Logo

Microvascular Flow and Reactivity in Patients Presenting in the Acute Phase of COVID-19.

NCT04406545 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 25

Last updated 2022-01-27

No results posted yet for this study

Summary

Considering that the intensity of systemic microvascular changes in patients in the acute phase of COVID-19 could be related to disease progression and prognosis, the present cross-sectional and observational study aims to investigate the presence of endothelial dysfunction in these patients, also looking for to evaluate associations between the presence of endothelial dysfunction and demographic, clinical and laboratory variables.

Conditions

  • Coronavirus Infection
  • Endothelial Dysfunction
  • Microvascular Rarefaction

Interventions

OTHER

evaluation of skin microvascular flow and reactivity

evaluation of skin microvascular flow and reactivity using laser Doppler perfusion monitoring

Sponsors & Collaborators

  • National Institute of Cardiology, Laranjeiras, Brazil

    lead OTHER_GOV

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-05-15
Primary Completion
2022-01-10
Completion
2022-01-10

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04406545 on ClinicalTrials.gov